24 Hrs
Source:
اقتصاد سكاي نيوز عربية
Novo Nordisk introduces Wegovy for easier obesity care
Novo Nordisk has launched the drug "Wegovy," which facilitates the treatment of obesity, boosting the company's growth alongside its diabetes and cardiovascular medications, and contributing to increased sales of the drug despite competition, as liver medications enter development phases.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)